WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

C CARDIOVASCULAR SYSTEM

This group comprises substances used for the treatment of cardiovascular conditions.
Drugs used for the treatment of hypertension are classified in C02 - Antihypertensives, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers, and C09 - Agents acting on the renin-angiotensin system. For the classification of combination products of antihypertensives from different ATC groups, the following ranking should be used, from higher to lower precedence: C09, C07, C08, and C03.


C07 BETA BLOCKING AGENTS
C07E BETA BLOCKING AGENTS AND VASODILATORS

This group comprises beta blocking agents and vasodilators (excl. calcium channel blockers) in combination.
Combinations with calcium channel blockers are classified in C07F.

See comments to C02L concerning the principles for assignment of DDDs for combined preparations.


C07EA Beta blocking agents, non-selective, and vasodilators
C07EB Beta blocking agents, selective, and vasodilators

Last updated: 2024-01-26